In the first nine months of this year, Valamar Riviera achieved revenue growth of 19 percent

first_imgValamar Riviera dd from Poreč, the leading tourism company in Croatia, in the first nine months of 2016 generated total operating revenues of HRK 1.487 million, which is an increase of 19 percent compared to the same period last year. In the first nine months of 2016, consolidated operating profit (EBITDA) grew by 18 percent.Strong revenue growth is the result of sales revenue growth of HRK 1.382 million through 4,93 million overnight stays, an increase of 8 percent, and an increase in the average price of over 5 percent, while non-board consumption increased by 27 percent compared to the same period last year. Revenue growth is the result of good results in the pre- and post-season through the successful implementation of major events in Dubrovnik and Porec, excellent business of hotels, resorts and camps of higher categories throughout the period, development of value-added services and destination products and acquisition of Hotels Baska ddSignificant added value for shareholders was realized, which is also reflected in the growth of market capitalization of 43 percent in the first nine months of this year. “The business results achieved in the first nine months of this year confirm the success of Valamar Riviera’s growth and development strategy, which is based on continuous investments in portfolios, employees and destinations with the aim of creating added value for shareholders and other stakeholders. Last year’s acquisition of Baška showed excellent results in improving business on the island of Krk, so we believe that Valamar’s presence on Rab will contribute to the further growth of the company and the development of tourism in this leading Croatian tourist destination. We are currently focused on the preparation of the business year 2017, during which Valamar will invest more than HRK 750 million in raising the quality of the portfolio and in the development of human resources, which are key to the continued growth of the company’s value.”, Pointed out Željko Kukurin, President of the Management Board of Valamar Riviera.Photo: FB ValamarIn 2016, Valamar Riviera expects to generate between HRK 1.460 and 1.475 million in operating revenues, ie an increase of 12,8 to 14 percent compared to last year. Revenue growth will be accompanied by strong growth in consolidated operating profit (EBITDA), which will reach between HRK 500 and 515 million annually, which is an increase of HRK 77 to 92 million or up to 22 percent compared to 2015. The announced investment cycle in 2017 represents the company’s largest investment in portfolio development in one year, and a large part relates to projects in Rabac – Family life Bellevue Resort 4 * and Girandella Resort 4 * and continued investment in premium camping.last_img read more

Stewardship / Resistance Scan for Mar 29, 2019

first_imgChinese surveillance study finds multidrug-resistant E coli in foodA surveillance study by Chinese scientists has found multidrug-resistant Escherichia coli strains in food products carrying the MCR-1 and blaNDM-1 resistance genes, and mobile genetic elements similar to those found in human strains, according to a paper yesterday in Eurosurveillance.Among the 1,166 non-repeated cephalosporin-resistant E coli isolates recovered from 2,137 samples of pork, beef, chicken, and shrimp bought at markets in Shenzen, China, from 2015 through 2017, the scientists identified 390 and 42, respectively, that were resistant to colistin and meropenem, and 5 isolates that were resistant to both antibiotics.Among the 390 colistin-resistant E coli isolates, the rate of resistance to colistin rose from 26% in 2015 to 46% in 2017, while rates of meropenem resistance in the 42 meropenem-resistant isolates increased from 0.3% in 2015 to 17% in 2017.Further screening found that all of the colistin-resistant isolates carried the MCR-1 gene and 36 of the 42 meropenem-resistant isolates carried the blaNDM-1 gene, with six harboring the blaNDM-5 gene; the five isolates that were resistant to both colistin and meropenem were carrying both MCR-1 and blaNDM genes. Notably, the scientists identified plasmids—in particular the ca 46kb IncX3 plasmid—that have been commonly reported in colistin- and carbapenem-resistant clinical isolates but not in isolates from animals and food. Conjugation experiments revealed that the colistin and meropenem resistance phenotypes of the 5 MCR-1 and blaNDM-bearing strains were transferable to other E coli strains of food origin.The authors of the study say the isolation of E coli strains harboring blaNDM-1 and MCR-1 that structurally resemble clinical strains has not previously been reported, and warn that the rising prevalence of these strains could mean an increase in severe, multidrug-resistant foodborne infections.”The increasing prevalence of Enterobacteriaceae strains carrying bla NDM and mcr-1 in food products will lead to increased colonisation of the human gastrointestinal tract with these Enterobacteriaceae strains, a phenomenon that has been associated with the high prevalence of drug-resistant infections in clinical settings,” they write. “Further surveillance of bla NDM-1 and mcr-1 in other food products is warranted.” Mar 28 Eurosurveill study Study in Georgia finds poor long-term outcomes for XDR-TB treatmentA study today in Open Forum Infectious Diseases reports high mortality among patients with extensively drug-resistant tuberculosis (XDR-TB) in the former Soviet republic of Georgia, with most deaths occurring post-treatment.In the retrospective population-based cohort study, researchers from Emory University and Georgia’s National Center for Tuberculosis and Lung Diseases assessed end-of-treatment and long-term outcomes in patients with XDR-TB. They also evaluated risk factors for poor outcomes. Patients were treated by directly observed therapy in accordance with 2011 World Health Organization (WHO) treatment guidelines for drug-resistant TB; the drug regimen did not include the newer agents bedaquiline and delamanid, which are now recommended under current WHO guidelines.From 2011 through 2013, 111 patients initiated treatment for XDR-TB; end-of-treatment outcomes were available for 106. Of those patients, 35 (33%) had a favorable outcome from initial XDR-TB treatment and 71 (67%) had an unfavorable outcome, with 16 (15.1%) dying. After cessation of initial XDR-TB treatment, an additional 20 of 90 (22.2%) patients who were alive at the end of treatment died, increasing the overall mortality rate to 34% (36 of 106). In multivariable analysis, the main factor for post-treatment mortality was unfavorable initial end-of-treatment outcome (adjusted odds ratio, 14.41; 95% confidence interval, 1.78 to 117.3).”The results of our study highlight the need for better surveillance during and after treatment for highly drug resistant TB,” the authors of the study write. “After treatment cessation, public health resources should focus on continual monitoring of patients given a significant risk of mortality and relapse.”Mar 29 Open Forum Infect Dis abstract Darden commits to buying chicken raised without antibiotics Multi-brand restaurant operator Darden Restaurants yesterday announced it will phase out the routine use of medically important antibiotics in its chicken supply chain by 2023.The commitment to buying chicken raised without medically important antibiotics is part of a wider animal welfare policy that the company, whose brands include Olive Garden and The Capital Grille, is adopting. The policy aims to increase mobility, lower injury and mortality rates, and reduce stress and fear among the farm animals in its supply chain.In addition to responsible use of antibiotics, Darden has identified humane housing, avoidance of pain, slaughter practices, and farm animal transportation as priority areas for improvement.Darden operates more than 1,700 restaurants in North America.Mar 28 Darden Restaurants press releaselast_img read more

National Drug Takeback Day

first_imgSouthampton Town is participating in the federal Drug Enforcement Agency’s National Drug Take Back Day Saturday, April 27.Because unused medications that are not disposed of can end up in the hands of the most vulnerable populations, like children, and flushing medications down a toilet could ultimately result in them entering the aquifer and polluting the drinking water, the town is hosting takebacks through its police department at three separate locations to help keep the community safe and clean.According to a 2017 National Survey on Drug Use and Health, six million Americans misused controlled prescription drugs that year. The study shows that most abused prescription drugs were obtained from family and friends, often from the home medicine cabinet. The DEA’s Take Back Day events provide an opportunity for Americans to prevent drug addiction and overdose deaths.Collection sites will be at Hampton Bays Community Center, 25 Ponquogue Avenue, Hampton Bays; Flanders Community Center, 655 Flanders Road, Flanders; and Southampton Town Police Substation at the Bridgehampton Commons, 2044 Montauk Highway, Bridgehampton, from 10 AM to 2 PM. Liquid medications, syringes, sharps, and thermometers are not accepted. The drop-off service is free and confidential. For more information about the disposal of prescription drugs or about the National Drug Take Back Day event, go to takebackday.dea.gov or call the Southampton Town Police Evidence & Property Section at 631-702-2254.desiree@indyeastend.com Sharelast_img read more

Beckham proceeding with plans to have MLS team in Miami

first_imgBeckham proceeding with plans to have MLS team in MiamiNews circulating last weekend that British soccer star, David Beckham plan to drop plans to bring a Major League Soccer team and build a stadium in South Florida was a rumor. The rumor also stated Beckham would take  the MLS franchise to Las Vegas being frustrated at attempts to secure a suitable stadium site in South Florida.However, Beckham’s South Florida investment group,  Miami Beckham United, told local media the British soccer icon is still making efforts to have the stadium located on a site in Overtown, Miami, while seeking additional investors for the project.The group, in a statement, said the investors are “100 percent committed to Miami,” and are making progress in their plans to have the stadium built in Overtown.According to reports, there is pressure on Beckham and his investment group to finalize their arrangements to launch the new MLS franchise in South Florida. The reports stated MLS Commissioner Don Garber has given a deadline to finalize the stadium deal in Miami, if not Beckham’s Miami franchise, which would be the 24th team in the MLS nationally, is in danger going to another team.Beckham has experienced several frustrating setbacks in securing a site for the soccer stadium in Miami since securing the MLS franchise in February, 2014. The group originally tried securing a site close to the Port of Miami, but met strong opposition from political and business leaders. Another attempt failed to locate the stadium  located adjacent to the Miami Marlins Park in Miami. Several months ago, the group settled on six acres of land it purchased in Overtown. The group has been in negotiations with Miami-Dade County to purchase an adjacent 3-acres to finalize the stadium site. With the estimated cost of the stadium being $150 million, the group has also been actively seeking new investors.West Kendall soccer coach Richard Donaldson, who with other local coaches are anxious for Beckham’s MLS team to commence playing in South Florida, expressed “sickening frustration at the ups and downs” in getting the stadium finalized. “Soccer is a promising, motivating sport for South Florida’s youth, male and female. The presence of a MLS team locally would be a great source of inspiration to the youth, helping them to improve their soccer skills. We really want this frustrating delay to end,” Donaldson said.last_img read more